Entries by Rob Coleman

Agilum Releases New York State COVID-19 Drug Utilization Trends Using Real-World Data (RWD) to Help Hospitals Predict Shifting Drug Demand

In response to the rapidly evolving COVID-19 pandemic, Agilum Healthcare Intelligence analyzed real-world data (RWD) from over 29% of the hospital beds in New York state to provide hospitals and pharmacists the evidence-based data to support their ability to predict the growing demand of certain drug inventory for the treatment and supportive care for COVID-19.

A new kind of healthcare intelligence with Agilum’s financial analytics team

The Agilum Healthcare Intelligence team is a fundamental component of Agilum’s commitment to unveiling your critical insights. Comprised of a multidisciplinary group of experienced healthcare business analysts and data experts, this team supports and augments an organization’s existing resources by analyzing their clinical, operational, financial and supply chain data to help manage profitability, boost departmental efficiency and optimize revenues. Recently, we sat down with Brian Wedderspoon, VP of Analytics Services, to learn more about what to expect with Agilum’s financial analytics solutions.

Know your numbers: A financial analytics maturity model

Finance leaders at health systems need to keep a sharp eye on the bottom line, yet many struggle to reliably calculate key performance measures.

Agilum has developed a financial analytics maturity model that empowers healthcare organizations to leverage data to manage teams and drive performance improvements across the board. It serves as a roadmap for finance leaders to understand how their performance is aligning to their goals and then pivot as necessary to achieve them.

A broken system — making drug decisions without real-world data

The spiraling cost of prescription drugs is creating unprecedented access and affordability challenges across our healthcare system. From hospital leaders to providers to patients to government, drug prices are on everyone’s radar. And with good cause: According to a January 2019 report from the American Hospital Association, total hospital and health system drug spend increased by 18.5 percent between 2015 and 2017.